Cargando…

Mediterranean diet and nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) is emerging as the most common chronic liver disease, and is characterized by a wide spectrum of fat-liver disorders that can result in severe liver disease and cirrhosis. Inflammation and oxidative stress are the major risk factors involved in the pathogenes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anania, Caterina, Perla, Francesco Massimo, Olivero, Francesca, Pacifico, Lucia, Chiesa, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960814/ https://www.ncbi.nlm.nih.gov/pubmed/29785077 http://dx.doi.org/10.3748/wjg.v24.i19.2083

Ejemplares similares

Cardiometabolic risk factors in children with celiac disease on a gluten-free diet
por: Anania, Caterina, et al.
Publicado: (2017)

Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis
por: Bonci, Enea, et al.
Publicado: (2015)

Nonalcoholic Fatty Liver Disease Is Associated With Low Skeletal Muscle Mass in Overweight/Obese Youths
por: Pacifico, Lucia, et al.
Publicado: (2020)

Aspartate transaminase to platelet ratio index (APRI) to assess liver fibrosis in patients with chronic liver disease
por: Anania, Caterina, et al.
Publicado: (2011)

Immune response to vaccines in children with celiac disease
por: Anania, Caterina, et al.
Publicado: (2017)

Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
por: Pacifico, Lucia, et al.
Publicado: (2018)

Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
por: Chackelevicius, Carla Melisa, et al.
Publicado: (2016)

Associations between nonalcoholic fatty liver disease and ischemic stroke
por: Alkagiet, Stelina, et al.
Publicado: (2018)

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
por: Pirola, Carlos J, et al.
Publicado: (2018)

Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics
por: Di Sessa, Anna, et al.
Publicado: (2021)

Emerging role of engineered exosomes in nonalcoholic fatty liver disease
por: Ding, Jian, et al.
Publicado: (2023)

Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
por: Mattos, Ângelo Z, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic
por: Ahmed, Musaab, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children
por: Di Costanzo, Alessia, et al.
Publicado: (2019)

Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current status
por: Kiseleva, Yana V, et al.
Publicado: (2023)

Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis
por: Zhang, Yang, et al.
Publicado: (2021)

Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system
por: Pirola, Carlos Jose, et al.
Publicado: (2021)

Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value
por: Li, Yu-Qi, et al.
Publicado: (2023)

The Impact of Nonalcoholic Fatty Liver Disease on Renal Function in Children with Overweight/Obesity
por: Pacifico, Lucia, et al.
Publicado: (2016)

Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives
por: Ueno, Masayuki, et al.
Publicado: (2022)

COVID-19 and pediatric fatty liver disease: Is there interplay?
por: Di Sessa, Anna, et al.
Publicado: (2021)

Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022)

The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease
por: Perla, Francesco M., et al.
Publicado: (2017)

Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis
por: Leoni, Simona, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

High Compliance to Mediterranean Diet Associates with Lower Platelet Activation and Liver Collagen Deposition in Patients with Nonalcoholic Fatty Liver Disease
por: Baratta, Francesco, et al.
Publicado: (2022)

Fatty liver and celiac disease: Why worry?
por: Narciso-Schiavon, Janaina Luz, et al.
Publicado: (2023)

Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease
por: Ristic-Medic, Danijela, et al.
Publicado: (2020)

Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
por: Baratta, Francesco, et al.
Publicado: (2019)

Diet and Lifestyle in Nonalcoholic Fatty Liver Disease
por: Martínez-Beamonte, Roberto, et al.
Publicado: (2020)

Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management
por: Wibawa, I Dewa Nyoman, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease and cardiovascular risk
por: Patil, Rashmee, et al.
Publicado: (2017)

Growing challenge of post-liver transplantation non-alcoholic fatty liver disease
por: Kalogirou, Maria Styliani, et al.
Publicado: (2022)

Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients
por: Yousef, Mohamad H, et al.
Publicado: (2017)

Mediterranean Diet: The Beneficial Effects of Lycopene in Non-Alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Metabolic associated fatty liver disease: Addressing a new era in liver transplantation
por: Gill, Madeleine G, et al.
Publicado: (2020)

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
por: Wong, Carrie R, et al.
Publicado: (2016)

Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Said, Adnan, et al.
Publicado: (2017)

Obese children with fatty liver: Between reality and disease mongering
por: Ranucci, Giusy, et al.
Publicado: (2017)

Management of metabolic-associated fatty liver disease: The diabetology perspective
por: Jeeyavudeen, Mohammad Sadiq, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_utls74odm8aeh69vr3a4srrq5s